health care provision. This is why I know that you need someone like me to explain about competition. It works in the high street because suppliers are trying to sell more washing machines and videos than there are customers wishing to buy them; the firms are therefore forced to compete on both price and quality, to the benefit of the consumer. In the NHS the reverse is true: demand exceeds supply and, what is more, the suppliers are working within strict cash limits. Competition and purchaser pressure may have forced hospitals to give more attention to some of the easily measurable quality issues such as waiting times and patient information leaflets-and a good thing toobut this will not increase efficiency. Indeed, the net result may well be to consume resources without producing any improvement in more important but less readily quantifiable criteria of outcome. Hospitals should be cooperating, not competing.
health care provision. This is why I know that you need someone like me to explain about competition. It works in the high street because suppliers are trying to sell more washing machines and videos than there are customers wishing to buy them; the firms are therefore forced to compete on both price and quality, to the benefit of the consumer. In the NHS the reverse is true: demand exceeds supply and, what is more, the suppliers are working within strict cash limits. Competition and purchaser pressure may have forced hospitals to give more attention to some of the easily measurable quality issues such as waiting times and patient information leaflets-and a good thing toobut this will not increase efficiency. Indeed, the net result may well be to consume resources without producing any improvement in more important but less readily quantifiable criteria of outcome. Hospitals should be cooperating, not competing.
When Kenneth Clarke first told us of his ideas these and other flaws were so obvious that many of us assumed that either we had analysed the situation incorrectly or that he too had spotted the pitfalls and had the solutions up his sleeve. We now realise that this was not the case. The NHS did need a kick up the backside, and a lot of us were (and still are) far more prepared than you realise to promote any scheme that looks halfway decent. Sadly, there was no discussion or consultation, and the present confrontational atmosphere was allowed to develop. It is depressing to see the predicted problems materialising one after another, and even more damaging to morale when it becomes apparent that the message we are trying to get across-that a so called free market is no way to ensure the satisfactory provision of health care to an aging population-has not been appreciated by those in a position to make a difference.
I work in a trust hospital which, as far as I can tell, has made a successful transition from directly managed status. Nevertheless, like everyone else we wonder how we can ever afford to replace the time expired capital equipment and infrastructure which was our legacy from the past 20 years of neglect. But if we are doing well someone else is doing badly-that is what free markets are like. We cannot afford to have failures in a health system which needs to use every hospital and every health care worker if it is to cope with the demands of the twenty first century.
Please listen to the arguments of those of us who are doing our best to make the new system work. The reforms are not all bad, and many of us can see opportunities opening up which we are eager to grab. Don't assume that we are all Luddite malcontents, afraid of change. Like you, we are committed to the NHS, and there is an enormous reserve of goodwill that you could be harnessing; just show some evidence that you appreciate the nature of the problems we are facing, and we can all work together to establish the quality service that our patients rightly demand.
Basic Molecular and Cell Biology
Cell to cell and cell to matrix adhesion It has been shown recently that adhesiveness of lymphocytes from patients with leucocyte adhesion deficiency can be restored by transfection with an expression vector continuing the complementary DNA for the normal 12 subunit.5 Thus gene therapy may be feasible for these patients. Mutation of the ,B3 subunit of the platelet integrin GPIIb/IIIa results in the bleeding disorder Glanzmann's thrombasthenia. The Bemard-Soulier syndrome entails a deficiency of the non-integrin platelet adhesion receptor GPIb/IX and von Willebrand's disease abnormalities of von Willebrand factor.
PEMPHIGUS
In pemphigus, the group of autoimmune diseases that cause epidermal blistering, patients' serum contains autoantibodies to desmosomes, the cadherinlike glycoproteins of the epidermal intercellular junctions. The autoantibodies cause the junctions to break down and the keratinocytes to separate (acantholysis) giving rise to the formation of blisters. Breakdown of desmosomes by another mechanism (possibly protease activity) gives rise to the inherited Darier's disease and Hailey-Hailey disease, which are similar but probably unrelated.
Failure of adhesion between the epidermis and its underlying basement membrane occurs in bullous pemphigoid, in which autoantibodies to cytoplasmic protein components of the matrix adhesive junctions known as hemidesmosomes are found in serum. 
